glp 1 drugs for binge eating disorder GLP-1 Agonist Disorder: Evidence and Safety New hope for binge eating
Description
Gilbert, D

GLP-1 receptor agonists have also been shown to cause weight loss in some individuals

doi: 10.1101/2023.11.19.23298750 [DOI] [PMC free article] [PubMed] [Google Scholar] 117.Wu T, Zhang Y, Shi Y, et al

Mounjaro (GLP-1 and GIP receptor agonist) is FDA-approved for the treatment of type 2 diabetes mellitus

The effects of GLP-1 analogues in obese, insulin-using type 2 diabetes in relation to eating behaviour

Clinical obesity 9(4):e12323 Jensterle M et al (2022) Efficacy of GLP-1 RA approved for weight management in patients with or without diabetes: a narrative review